Icro Meattini MD; 2026 EBCC: Safe to Avoid Endocrine Therapy in Older Women with Low Risk Breast Cancers: EUROPA Study Interim Findings
About this episode
The episode discusses the findings of the EUROPA study, which suggests that older women with low-risk breast cancers can safely avoid endocrine therapy after radiotherapy.
Safe to Avoid Endocrine Therapy in Older Women with Low Risk Breast Cancers: EUROPA Study Interim Findings An interview with: Icro Meattini MD, Associate Professor of Radiotherapy, University of Florence, Clinical Oncologist, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Italy BARCELONA, Spain—More evidence has emerged showing that older women with breast cancers that are not life threatening can safely receive only radiotherapy after breast conserving therapy, without adding hormone treatments. At the 2026 European Breast Cancer Conference emerging findings from the EUROPA study of women over 70 with “luminal-like” early breast cancer were discussed by Icro Meattini MD, Associate Professor of Radiotherapy at the University of Florence, and Clinical Oncologist at Azienda Ospedaliero-Universitaria Careggi, University of Florence, Italy. He talked with Peter Goodwin about the findings and clinical implications: AUDIO JOURNAL OF ONCOLOGY: Iccro Mettini MD IN: [GOODWIN]”Peter Goodwin here in Barcelona….. OUT: ….. of Oncology, I’m Peter Goodwin 2026 European Breast Cancer Conference: “EUROPA Study: Endocrine or Radiation Therapy for Elderly Patient with…
More episodes of Audio Journal of Oncology Podcast
- Jonathan Wesley Riess MD; 2026 AACR: Investigational KRAS(ON) Inhibitor Zoldonrasib Showed Effective and Durable Responses in Patients With Advanced G12D-mutated Lung Cancer
- Tao Zhu MD; AACR 2026: Anti-Claudin 6 Antibody Drug Conjugate Benefits Patients with Advanced Platinum-Resistant Ovarian Cancer with Low Toxicity
- Moran Amit MD PhD; AACR 2026: Oral Intralesional PD 1 Blockade Promises Less Risk of Progression to Oral Cancer than Surgery, with Preserved Quality of Life
- Byoung Chul Cho MD PhD; AACR 2026: New Generation KRAS G12C Inhibitor Brings Promising Responses Even in Patients with Advanced Lung Cancers Refractory to Previous KRAS-targeted Therapy
- Elena Garralda MD PhD, AACR 2026: Molecular Glue Degrader Improves Outcomes in Heavily Pre-treated Patients with Advanced Solid Tumors
- Amparo Garcia-Tejedor MD, PhD; 2026 EBCC: Axillary Radiotherapy Seems As Effective as Axillary Lymphadenectomy in Sentinel Node Positive Early Breast Cancer, with Less Risk of Lymphedema
Explore listener stats, chart rankings, contacts and more on the Audio Journal of Oncology Podcast podcast page.